Pan-European agentic infrastructure, First human cornea transplant using 3D-bioprinting, TOXBOX, and more

NAMs News

Actus des méthodes non-animales

DECEMBER 01 - 05, 2025

Pro Anima > Actualités > NAMs News - DECEMBER 01 - 05, 2025
Pan-European agentic infrastructure, First human cornea transplant using 3D-bioprinting, TOXBOX, and more
NAMs News - OCTOBER 20 - 24, 2025

Alternatives to animal testing are the future, NC3Rs report on NAMs infrastructures, FDA’s CDER Inventory for NAMs, QKARs for enhanced drug toxicity prediction, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Nature commentary on NAMs: Alternatives to animal testing are the future A new commentary […]

Read more
NAMs News - OCTOBER 13 - 17, 2025

Japan joining the NAMs momentum, BiMMoH database launch, Charles River and Toxys new collaboration, Immune-competent lung-on-a-chip and more

NEWS, REPORTS & POSITION STATEMENTS 1. Japan has joined the NAMs momentum The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) […]

Read more
NAMs News - OCTOBER 06 - 10, 2025

OECD: Guidance on omics, NAMs for DART, Biotech Act, 2026 MPS World Summit Call for abstract, Deciphering brain organoids and more

NEWS, REPORTS & POSITION STATEMENTS 1. OECD: Guidance on good practices and standardisation of omics data Omics technologies are increasingly being […]

Read more
NAMs News - SEPT 29 - OCT 03, 2025

OOC regulatory perspective, Incorporating NAMs into medicines development, NIH Organoids SOM Center and Replication Prize, and more

NEWS, REPORTS & POSITION STATEMENTS 1. European Commission scientific strategies for sovereignty Strategy on Research and Technology Infrastructures On 15 […]

Read more
NAMs News - SEPTEMBER 22 - 26, 2025

AI-Powered On-Chip Systems, NIH landmark whole-person project, ASPIS Winners, Embolization-on-a-chip

NEWS, REPORTS & POSITION STATEMENTS 1. Top 5 Must-Read Articles on AI-Powered On-Chip Systems AI is colliding with organoids, organs-on-chips, […]

Read more
NAMs News - SEPT. 15 - 19 2025

French O&OOC industry collective appeal, ToxTracker® Approved by OECD, Psychedelics meet human brain organoids

NEWS, REPORTS & POSITION STATEMENTS 1. Urgent relaunch of the AFNOR S96R commission: F3OCI collective appeal The French organoid and […]

Read more
NAMs News - SEPTEMBER 08 - 12, 2025

Putting human biology at the center, AI lab-pilot transition, First self-contained OoC workstation, Organoids as immune-organ interaction models

NEWS, REPORTS & POSITION STATEMENTS 1. The drug development shift: Putting human biology at the center The biopharma industry continues […]

Read more
NAMs News - SEPT. 01 - 05, 2025

ESTIV New Award, EMA qualification for Certara, BioBricks: New open-source Data-Hub, Novel Antibiotics by GenAI, OwkinZero: Biological reasoning blind spot in current LLMs

NEWS, REPORTS & POSITION STATEMENTS 1. Bringing scientific methods into regulatory guidelines Many innovative, animal-free methods never make it into […]

Read more
NAMs News - JULY 07 - 11, 2025

DILI detection, NIH Strategic Plan for Data Science, Human relevance assessment of AOPs, PEPPER and Young TPI calls, OrganoidChip+ and more

The NAM newsletter will be back in September Wishing you a beautiful summer    NEWS, REPORTS & POSITION STATEMENTS 1. […]

Read more
NAMs News - JUNE 23 - 27, 2025

ECHA report on key areas of regulatory challenge, Maximising NAMs in food safety assessment, NIH paradigm-shifting funding step, Human Liver Toxicity Dataset and more

NEWS, REPORTS & POSITION STATEMENTS 1. ECHA updated report on Key Areas of Regulatory Challenge The European Chemicals Agency (ECHA) […]

Read more
NAMs News - JUNE 16 - 20, 2025

NAMs: a ‘Complement’ to animal experimentation?, IHB New Co-Director for computational biology, Preclinical: Vivodyne replaces animal testing, A Bioprinted 3D lung model and more

NEWS, REPORTS & POSITION STATEMENTS 1. 3rd European Commission workshop to establish its roadmap for the phasing out of animal […]

Read more
NAMs News - JUNE 09 - 13, 2025

Organoid biobanks, Shaping Standards for the MPS, Two global partnerships: InSphero x Tessara Therapeutics & Merck x imec, Stanford breakthrough in vascularized organoids and more

NEWS, REPORTS & POSITION STATEMENTS 1. Organoid biobanks: a breakthrough — but for whom? Organoids are reshaping biomedical research and drug development by […]

Read more
Donate
MENU